お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
972201

アンチセンスおよびRNAi治療薬の世界市場(2020年~2030年):Covid-19による成長と変化

Antisense & RNAi Therapeutics Global Market Report 2020-30: Covid 19 Growth and Change

出版日: 受注生産 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.84円
アンチセンスおよびRNAi治療薬の世界市場(2020年~2030年):Covid-19による成長と変化
出版日: 受注生産
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 目次
概要

当レポートは、世界のアンチセンスおよびRNAi治療薬市場について調査しており、市場規模と予測、動向、戦略、シェア、成長および抑制要因、技術・投与経路・適応症・地域/国別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場規模と成長

  • 世界市場(2015-2019)
    • 市場成長要因
    • 市場抑制要因
  • 世界市場予測(2019-2023F、2025F、2030F)

第4章 市場セグメンテーション

  • 世界市場および予測:技術別(2015-2019、2023F、2025F、2030F)
  • RNAi
  • アンチセンスRNA
  • 世界市場および予測:投与経路別(2015-2019、2023F、2025F、2030F)
  • 肺送達
  • 静脈内注射
  • 皮内注射
  • 腹腔内注射
  • 局所送達
  • その他
  • 世界市場および予測:適応症別(2015-2019、2023F、2025F、2030F)
  • 腫瘍学
  • 心血管疾患(CVD)
  • 呼吸器疾患
  • 神経学的障害
  • 感染症
  • その他

第5章 地域/国別分析

  • 世界市場および予測:地域別(2015-2019、2023F、2025F、2030F)
  • 世界市場および予測:国別(2015-2019、2023F、2025F、2030F)

第6章 アジア太平洋地域

第7章 中国

第8章 インド

第9章 日本

第10章 オーストラリア

第11章 インドネシア

第12章 韓国

第13章 西欧

第14章 英国

第15章 ドイツ

第16章 フランス

第17章 東欧

第18章 ロシア

第19章 北米

第20章 米国

第21章 南米

第22章 ブラジル

第23章 中東

第24章 アフリカ

第25章 競合情勢と企業プロファイル

  • 競合情勢
  • 企業プロファイル
    • Alnylam Pharmaceuticals
    • Benitec Biopharma Ltd.
    • Gene Signal
    • GlaxoSmithKline Plc
    • Ionis Pharmaceuticals

第26章 市場における主な合併と買収

第27章 市場動向と戦略

第28章 市場の将来展望と潜在的分析

第29章 付録

目次

“Antisense & RNAi Therapeutics Global Market Report 2020-30: COVID-19 Growth and Change” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global antisense & RNAi therapeutics market.

This report focuses on antisense & RNAi therapeutics market which is experiencing strong growth. The report gives a guide to the antisense & RNAi therapeutics market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the antisense & RNAi therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Antisense & RNAi Therapeutics market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider antisense & RNAi therapeutics market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The antisense & RNAi therapeutics market section of the report gives context. It compares the antisense & RNAi therapeutics market with other segments of the antisense & RNAi therapeutics market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, antisense & RNAi therapeutics indicators comparison.

Scope

Markets Covered:

  • 1) By Technology: RNA Interference; Antisense RNA
  • 2) By Route of Administration: Pulmonary Delivery; Intravenous Injections; Intra-dermal Injections; Intraperitoneal Injections; Topical Delivery; Other Delivery Methods
  • 3) By Indication: Oncology; Cardiovascular Diseases (CVDs); Respiratory Disorders; Neurological Disorders; Infectious Diseases; Other
  • Companies Mentioned: Alnylam Pharmaceuticals; Benitec Biopharma Ltd.; Gene Signal; GlaxoSmithKline Plc; Ionis Pharmaceuticals
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series:: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Antisense & RNAi Therapeutics Market Characteristics

3. Antisense & RNAi Therapeutics Market Size And Growth

  • 3.1. Global Antisense & RNAi Therapeutics Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Antisense & RNAi Therapeutics Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Antisense & RNAi Therapeutics Market Segmentation

  • 4.1. Global Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • RNA Interference
  • Antisense RNA
  • 4.2. Global Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Pulmonary Delivery
  • Intravenous Injections
  • Intra-dermal Injections
  • Intraperitoneal Injections
  • Topical Delivery
  • Other Delivery Methods
  • 4.3. Global Antisense & RNAi Therapeutics Market, Segmentation By Indication, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oncology
  • Cardiovascular Diseases (CVDs)
  • Respiratory Disorders
  • Neurological Disorders
  • Infectious Diseases
  • Other

5. Antisense & RNAi Therapeutics Market Regional And Country Analysis

  • 5.1. Global Antisense & RNAi Therapeutics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Antisense & RNAi Therapeutics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Antisense & RNAi Therapeutics Market

  • 6.1. Asia-Pacific Antisense & RNAi Therapeutics Market Overview
  • 6.2. Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Antisense & RNAi Therapeutics Market

  • 7.1. China Antisense & RNAi Therapeutics Market Overview
  • 7.2. China Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
  • 7.3. China Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Antisense & RNAi Therapeutics Market

  • 8.1. India Antisense & RNAi Therapeutics Market Overview
  • 8.2. India Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 8.3. India Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Antisense & RNAi Therapeutics Market

  • 9.1. Japan Antisense & RNAi Therapeutics Market Overview
  • 9.2. Japan Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 9.3. Japan Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Antisense & RNAi Therapeutics Market

  • 10.1. Australia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 10.2. Australia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Antisense & RNAi Therapeutics Market

  • 11.1. Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Antisense & RNAi Therapeutics Market

  • 12.1. South Korea Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Antisense & RNAi Therapeutics Market

  • 13.1. Western Europe Antisense & RNAi Therapeutics Market Overview
  • 13.2. Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Antisense & RNAi Therapeutics Market

  • 14.1. UK Antisense & RNAi Therapeutics Market Overview
  • 14.2. UK Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 14.3. UK Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Antisense & RNAi Therapeutics Market

  • 15.1. Germany Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 15.2. Germany Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Antisense & RNAi Therapeutics Market

  • 16.4. France Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 16.5. France Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Antisense & RNAi Therapeutics Market

  • 17.1. Eastern Europe Antisense & RNAi Therapeutics Market Overview
  • 17.2. Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Antisense & RNAi Therapeutics Market

  • 18.1. Russia Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 18.2. Russia Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Antisense & RNAi Therapeutics Market

  • 19.1. North America Antisense & RNAi Therapeutics Market Overview
  • 19.2. North America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 19.3. North America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Antisense & RNAi Therapeutics Market

  • 20.1. USA Antisense & RNAi Therapeutics Market Overview
  • 20.2. USA Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 20.3. USA Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Antisense & RNAi Therapeutics Market

  • 21.1. South America Antisense & RNAi Therapeutics Market Overview
  • 21.2. South America Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 21.3. South America Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Antisense & RNAi Therapeutics Market

  • 22.1. Brazil Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Antisense & RNAi Therapeutics Market

  • 23.1. Middle East Antisense & RNAi Therapeutics Market Overview
  • 23.2. Middle East Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Antisense & RNAi Therapeutics Market

  • 24.1. Africa Antisense & RNAi Therapeutics Market Overview
  • 24.2. Africa Antisense & RNAi Therapeutics Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 24.3. Africa Antisense & RNAi Therapeutics Market, Segmentation By Route of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Antisense & RNAi Therapeutics Market Competitive Landscape And Company Profiles

  • 25.1. Antisense & RNAi Therapeutics Market Competitive Landscape
  • 25.2. Antisense & RNAi Therapeutics Market Company Profiles
    • 25.2.1. Alnylam Pharmaceuticals
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Benitec Biopharma Ltd.
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Gene Signal
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. GlaxoSmithKline Plc
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Ionis Pharmaceuticals
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Antisense & RNAi Therapeutics Market

27. Antisense & RNAi Therapeutics Market Trends And Strategies

28. Antisense & RNAi Therapeutics Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.